University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 20 of 35
Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation (The ONE Study )
NCT02244801
Enhancing PrEP in Community Settings (EPIC)
NCT02371525
Mindfulness Based Stress Reduction for Older Adults With HIV Associated Neurocognitive Disorders
NCT02936401
Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma
NCT02587650
Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle Model
NCT02451345
Care Ecosystem: Navigating Patients and Families Through Stages of Care
NCT02213458
Paired Integrative Home Exercise for Seniors With Dementia and Their Caregivers (PairedPLIE)
NCT02403752
Group Acupuncture Treatment Effects for Painful Diabetic Neuropathy (GATE-PDN)
NCT02104466
Uterotonic Prophylaxis Trial
NCT02408965
National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC
NCT03982459
Pilot #2 of Social Network Intrauterine Contraceptive (IUC) Intervention
NCT02242890
A Prospective Analysis of Preoperative Fascia Iliaca Block for Hip Arthroscopy
NCT02623361
Rosuvastatin Interethnic PK Study
NCT02215174
Pilot Study of Coil Arrays in Patients With Advanced Solid Tumor Malignancies
NCT02390011
Early Limited Formula for Treating Lactation Concerns
NCT02313181
Lessening Incontinence Through Low-impact Activity
NCT02342678
Online Neuropsychological Test Validation Project With Imaging Pilot
NCT02486250
MoTHER Buddy Program
NCT02338765
Paleo Versus Healthy ADA Diets for Treatment of Polycystic Ovarian Syndrome (PCOS)
NCT02190097
TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve
NCT02147301
Mortality Reduction After Oral Azithromycin: Mortality Study
NCT02047981
Tacrolimus Adjustment by NFAT-related Gene Expression in Lung Allograft Recipients.
NCT02278952
Diabetes Prevention Among Post-partum Women With History of Gestational Diabetes
NCT02240420
A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal
NCT02317276
Aides in Respiration Health Coaching for COPD
NCT02234284
PilAm Go4Health Weight Loss Program to Prevent Heart Disease
NCT02290184
Fit and Trim for Diabetes Prevention
NCT02278939
Mortality Reduction After Oral Azithromycin: Morbidity Study
NCT02048007
The Effects of Rifampin on the Pharmacokinetics of Rosuvastatin
NCT02106767
Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade Glioma
NCT02022644
Evaluation of Rectal Cancer Treatment Response Using PET/MRI
NCT02233595
Program to Overcome Pelvic Pain With Yoga
NCT02261740
Tobacco Status Project: Social Media Intervention for Young Adult Smokers
NCT02207036
Patient-Centered Support for Contraceptive Decision-Making
NCT02078713
Primary Care Beverage Study
NCT02257203
Fatigue Management in HIV
NCT02126007
Fecal Microbiota Transplantation in HIV
NCT02256592
The OneFreeze Study
NCT02217254
Dichoptic Virtual Reality Therapy for Amblyopia in Adults
NCT02246556
Molecular Profiling for Individualized Treatment Plan for DIPG
NCT02274987
Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer
NCT02215161
Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDS) on Acclimatization to High Altitude
NCT02233582
Reducing Distress And Improving Glycemic Control In Adults With Type 1 Diabetes
NCT02175732
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
NCT02365922
Gender-Responsive Drug Use Treatment for Juvenile Justice Girls
NCT02293057
Administration of Follicle-stimulating Hormone (FSH) and Low Dose Human Chorionic Gonadotropin (hCG) for Oocyte Maturity While Decreasing hCG Exposure in In Vitro Fertilization (IVF) Cycles
NCT02310919
Preparing Spanish-speaking Older Adults for Advance Care Planning and Medical Decision Making (PREPARE)
NCT02072941
Controlling Urgency Through Relaxation Exercises
NCT02202031
Molecular Profiling in Guiding Individualized Treatment Plan in Adults With Recurrent/Progressive Glioblastoma
NCT02060890
Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease
NCT01771731
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.